找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Gallbladder Cancer; Current Treatment Op Vijay Kumar Shukla,Manoj Pandey,Ruhi Dixit Book 2023 The Editor(s) (if applicable) and The Author(

[復(fù)制鏈接]
樓主: ARGOT
41#
發(fā)表于 2025-3-28 16:55:18 | 只看該作者
42#
發(fā)表于 2025-3-28 18:59:41 | 只看該作者
43#
發(fā)表于 2025-3-29 02:17:24 | 只看該作者
https://doi.org/10.1007/978-3-663-09225-4common symptoms present at an advanced stage. Conventional chemotherapy and radiation have not shown much improvement in terms of survival and quality of life. MicroRNA technology is a novel and exciting development in cancer diagnostic and therapeutic and may potentially address shortcomings relate
44#
發(fā)表于 2025-3-29 03:48:06 | 只看該作者
45#
發(fā)表于 2025-3-29 10:44:39 | 只看該作者
Agenda-Setting zwischen Parlament und Medienrld precluded it from active research for the last two decades. Gemcitabine- and platinum-based combination therapy remained the treatment of choice over these years. Delayed presentations and aggressive biology made this disease largely incurable in early disease state and goal remains palliative i
46#
發(fā)表于 2025-3-29 13:02:51 | 只看該作者
47#
發(fā)表于 2025-3-29 17:09:40 | 只看該作者
48#
發(fā)表于 2025-3-29 19:56:44 | 只看該作者
The Analysis of Business Processestage of disease. There is a need for an effective treatment regimen to circumvent the high mortality rate. Current therapeutic approach is the surgical resection followed by chemotherapy and radiotherapy. Recent advancements in high throughput sequencing technology, whole proteome and transcriptome
49#
發(fā)表于 2025-3-30 03:06:24 | 只看該作者
Vijay Kumar Shukla,Manoj Pandey,Ruhi DixitSurgical Management, Adjuvant Chemotherapy and Palliative Chemotherapy in gallbladder cancer.Targeted Therapies in gallbladder cancer.Clinical trials in gallbladder cancer treatment
50#
發(fā)表于 2025-3-30 07:22:23 | 只看該作者
https://doi.org/10.1007/978-981-19-6442-8Gallbladder Cancer; Cholelithiasis; Cholecystectomy; Chemotherapy; Therapeutics
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 18:34
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
乡城县| 长汀县| 晴隆县| 肇东市| 如皋市| 汤原县| 馆陶县| 隆化县| 汉中市| 体育| 西贡区| 平顺县| 江门市| 镇平县| 阜平县| 淮滨县| 奉新县| 商城县| 长治县| 青龙| 乾安县| 内乡县| 小金县| 会宁县| 张掖市| 白水县| 舟曲县| 大洼县| 铅山县| 尉氏县| 太康县| 宁津县| 福泉市| 博湖县| 高雄县| 察哈| 连平县| 新密市| 秭归县| 信宜市| 鱼台县|